Welcomed the team from #SepulBio, who are sponsoring the antisense oligonucleotide #Ultevursen clinical trial for #UsherSyndrome, to @moorfields.bsky.social @moorfieldsbrc.bsky.social for a tour of our Clinical Research Facility.

It was my pleasure to speak at the #patient day for #USH2025 in Nijmegen today. I was able to share details of the multicentre international phase 2 #Ultevursen clinical trial run by #SepulBio for individuals with exon 13 mutations in the #USH2A gene.